A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists
(Q43940109)
scientific article published on 28 March 2002
scientific article published on 28 March 2002
Language:
Current Data About
A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists
other details
description | scientific article published on 28 March 2002 |
External Links
(P356) |
10.1074/JBC.M200889200
|
(P698) |
11923301
|